Top news of the week from The American Journal of Pharmacy Benefits.
While antibiotics are the mainstay for treatment, the role of corticosteroids for adjunctive treatment of community-acquired pneumonia has long remained controversial. Read here.
Tenofovir alafenamide plus emtricitabine, which belongs in the class of nucleoside reverse transcriptase inhibitors, poses little risk for bone or renal toxicity in virologically suppressed patients with HIV. Read more.
Condition-specific readmissions measures for heart failure, pneumonia, and heart attack may not accurately or fairly reflect hospital quality. Read more.
A comprehensive evaluation of the 2016 US drug overdose data indicates that the opioid epidemic has spread geographically and increased across demographic groups. Read more.
President Donald J. Trump last Friday signed the $1.3 trillion omnibus spending bill, which provides full-year appropriations through September 30, 2018, for projects and activities of the federal government. Read more.